perfluorooctane sulfonic acid has been researched along with Disease Models, Animal in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 4 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Chávez, MN; Das, S; Diaz, OE; Frede, A; Krais, AM; Luo, X; Morales, RA; Sorini, C; Villablanca, EJ; Wincent, E | 1 |
| An, P; Li, X; Lu, H; Ma, B; Xiong, Y; Xu, H; Zhao, H; Zhao, Y; Zhou, Q | 1 |
| Anderson, D; Auclair, A; Barlock, B; Cummings, BS; Ingram, L; Jamwal, R; Marques, E; Pfohl, M; Slitt, AL | 1 |
| Fan, Z; Qiu, J; Suo, C; Zhou, L | 1 |
| Chang, CC; Chou, HC; Jin, L; Juan, SH; Lin, CY; Wen, LL | 1 |
| Hu, Y; Innes, K; Kamarec, S; Montgomery, C; Thomas, L; Villers, M; Wimsatt, J; Yeung, LW | 1 |
| Billah, MB; Chan, TF; Cheung, A; Lai, KP; Li, JW; Li, R; Wong, CKC | 1 |
| DeWitt, JC; Germolec, DR; Keller, JM; Peden-Adams, MM | 1 |
| Abedi-Valugerdi, M; DePierre, JW; Hassan, M; Nelson, BD; Qazi, MR | 1 |
| Eriksson, P; Fredriksson, A; Johansson, N | 1 |
1 review(s) available for perfluorooctane sulfonic acid and Disease Models, Animal
| Article | Year |
|---|---|
Immunotoxicity of perfluorinated compounds: recent developments.
Topics: Alkanesulfonic Acids; Animals; Caprylates; Disease Models, Animal; Environmental Pollutants; Fluorocarbons; Humans; Immune System; Immunotoxins | 2012 |
10 other study(ies) available for perfluorooctane sulfonic acid and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Perfluorooctanesulfonic acid modulates barrier function and systemic T-cell homeostasis during intestinal inflammation.
Topics: Alkanesulfonic Acids; Animals; Colitis; Cytokines; Disease Models, Animal; Fluorocarbons; Homeostasis; Inflammation; Intestinal Mucosa; Mice; Trinitrobenzenesulfonic Acid; Zebrafish | 2021 |
Perfluorooctane sulfonate exposure induces preeclampsia-like syndromes by damaging trophoblast mitochondria in pregnant mice.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Female; Humans; Hypertension; Mice; Mitochondria; Placenta; Pre-Eclampsia; Pregnancy; Syndrome; Trophoblasts | 2022 |
Perfluorooctanesulfonic Acid and Perfluorohexanesulfonic Acid Alter the Blood Lipidome and the Hepatic Proteome in a Murine Model of Diet-Induced Obesity.
Topics: Alkanesulfonic Acids; Animals; Diet, High-Fat; Disease Models, Animal; Fluorocarbons; Lipidomics; Liver; Male; Mice; Mice, Inbred C57BL; Obesity; Proteome; Sulfonic Acids | 2020 |
Perfluorooctane sulfonate affects intestinal immunity against bacterial infection.
Topics: Alkanesulfonic Acids; Animals; Bacterial Infections; Cytokines; Disease Models, Animal; Fluorocarbons; Inflammation Mediators; Intestines; Mice; Mucins; Severity of Illness Index; Th17 Cells | 2017 |
From the Cover: l-Carnitine via PPARγ- and Sirt1-Dependent Mechanisms Attenuates Epithelial-Mesenchymal Transition and Renal Fibrosis Caused by Perfluorooctanesulfonate.
Topics: Acetylation; Alkanesulfonic Acids; Animals; Carnitine; Cell Line; Cell Movement; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Epithelial Cells; Epithelial-Mesenchymal Transition; Fibrosis; Fluorocarbons; Kidney Diseases; Kidney Tubules; Male; Mice, Inbred BALB C; PPAR gamma; Protective Agents; Rats; Signal Transduction; Sirtuin 1; Time Factors; Transfection | 2017 |
Oral perfluorooctane sulfonate (PFOS) lessens tumor development in the APC
Topics: Adenomatous Polyposis Coli; Adenomatous Polyposis Coli Protein; Administration, Oral; Alkanesulfonic Acids; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluorocarbons; Male; Mice; Mice, Inbred C57BL | 2016 |
Transcriptome sequencing reveals prenatal PFOS exposure on liver disorders.
Topics: Alkanesulfonic Acids; Animals; Cell Transformation, Neoplastic; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Environmental Pollutants; Fatty Acids; Female; Fetal Diseases; Fluorocarbons; Lipid Metabolism; Male; Mice; Neoplasms; Pregnancy; Prenatal Exposure Delayed Effects; Transcriptome | 2017 |
Both sub-acute, moderate-dose and short-term, low-dose dietary exposure of mice to perfluorooctane sulfonate exacerbates concanavalin A-induced hepatitis.
Topics: Alkanesulfonic Acids; Animals; Apoptosis; Chemical and Drug Induced Liver Injury; Concanavalin A; Cytokines; Disease Models, Animal; Disease Progression; DNA Fragmentation; Dose-Response Relationship, Drug; Environmental Pollutants; Fluorocarbons; Hepatomegaly; Immunologic Factors; Liver; Male; Mice; Mice, Inbred C57BL; Random Allocation; Time Factors; Transaminases | 2013 |
Neonatal exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) causes neurobehavioural defects in adult mice.
Topics: Alkanesulfonic Acids; Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Brain Diseases; Caprylates; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Fluorocarbons; Locomotion; Male; Maze Learning; Mental Disorders; Mice; Nicotine; Nicotinic Agonists; Pregnancy; Time Factors | 2008 |